For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Effect of dimethyl sulfoxide on transformed rat Schwann cells.

TitleEffect of dimethyl sulfoxide on transformed rat Schwann cells.
Publication TypeJournal Article
Year of Publication1987
AuthorsSutrina SL, Lue NF, Chen GL, Chen WW
JournalBiochim Biophys Acta
Volume923
Issue3
Pagination451-62
Date Published1987 Mar 19
ISSN0006-3002
KeywordsAnimals, Cell Division, Cell Survival, Cell Transformation, Viral, Dimethyl Sulfoxide, Galactose, Galactosylceramides, Glucosamine, Glycoproteins, Glycosaminoglycans, Lipids, Mannose, Monensin, Proteins, Rats, Schwann Cells, Sulfates, Sulfoglycosphingolipids
Abstract

Cultured rat Schwann cells transformed by Simian Virus 40 (SV40) have previously been shown to retain their ability to synthesize myelin-associated galactosylceramide and sulfatide. Little is known about the mechanism regulating galactosphingolipid synthesis in Schwann cells. We have found that growing the transformed Schwann cells in the presence of dimethyl sulfoxide (DMSO) markedly inhibits the incorporation of [35S]sulfate into sulfatide, in a time- and dose-dependent manner. The concentration of DMSO which resulted in a half-maximal inhibition after 6 days of incubation was 0.5%, and the incubation time required for a half-maximal effect at 1.0% DMSO was approximately 4 days. In contrast, DMSC did not affect the incorporation of [35S]sulfate into glycosaminoglycans. In addition, DMSO treatment has little effect on the synthesis of cellular DNA, proteins and lipids. When transformed Schwann cells were treated with DMSO, a substantial decrease in the incorporation of [3H]galactose into galactosylceramide was observed. The concentration of DMSO which resulted in a half-maximal inhibition of galactosylceramide synthesis was approximately 0.5%, similar to the concentration required for a similar effect on sulfatide synthesis. However, the incubation time required for a half-maximal inhibitory effect on galactosylceramide synthesis at 1.0% DMSO was less than 1 day, which was substantially shorter than the time required for the inhibition of sulfatide synthesis at this concentration. This finding is consistent with the interpretation that treatment with DMSO inhibits the synthesis of galactosylceramide, a precursor of sulfatide, which results in a decrease in the synthesis of sulfatide during a prolonged incubation of DMSO.

DOI10.1016/0304-4165(87)90054-7
Alternate JournalBiochim Biophys Acta
PubMed ID3828387
Grant ListHD-10981 / HD / NICHD NIH HHS / United States
HL-06531 / HL / NHLBI NIH HHS / United States
NS-16955 / NS / NINDS NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587